[
    [
        {
            "time": "",
            "original_text": "泰格医药(03347)股东曹晓春新增质押260万股及解除质押250万股",
            "features": {
                "keywords": [
                    "泰格医药",
                    "股东",
                    "曹晓春",
                    "新增质押",
                    "解除质押"
                ],
                "sentiment_score": -0.1,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "泰格医药(03347)股东曹晓春新增质押260万股及解除质押250万股",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "泰格医药：股东曹晓春累计质押股数为1040万股",
            "features": {
                "keywords": [
                    "泰格医药",
                    "股东",
                    "曹晓春",
                    "累计质押"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "泰格医药：股东曹晓春累计质押股数为1040万股",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "泰格医药(300347)：上半年业绩恢复快速增长 回购彰显未来发展信心",
            "features": {
                "keywords": [
                    "泰格医药",
                    "上半年业绩",
                    "快速增长",
                    "回购",
                    "发展信心"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药(300347)：上半年业绩恢复快速增长 回购彰显未来发展信心",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "麦格理：将泰格医药H股评级上调至跑赢大盘，目标价191.17港元。",
            "features": {
                "keywords": [
                    "麦格理",
                    "泰格医药",
                    "H股",
                    "评级上调",
                    "跑赢大盘",
                    "目标价"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "麦格理：将泰格医药H股评级上调至跑赢大盘，目标价191.17港元。",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]